Tamara van Donge

Physiological changes during pregnancy and neonatal life 37 2 35. Manokhina I, Del Gobbo GF, Konwar C, Wilson SL, Robinson WP. placental biomarkers for assessing fetal health. Human molecular genetics. 2017;26(R2):R237-R245. 36. van den Anker J, Reed MD, Allegaert K, Kearns GL. Developmental changes in pharmacokinetics and pharmacodynamics. The Journal of Clinical Pharmacology. 2018;58:S10-S25. 37. Koren G. Therapeutic drug monitoring principles in the neonate. Clinical chemistry. 1997;43(1):222- 227. 38. Bonner JJ, Vajjah P, Abduljalil K, et al. Does age affect gastric emptying time? A model‐based meta‐analysis of data from premature neonates through to adults. Biopharmaceutics & drug disposition. 2015;36(4):245-257. 39. Ku LC, Smith PB. Dosing in neonates: special considerations in physiology and trial design. Pediatric research. 2014;77(1-1):2. 40. Seyberth HW, Kauffman RE. Basics and dynamics of neonatal and pediatric pharmacology. Pediatric Clinical Pharmacology : Springer; 2011:3-49. 41. Kastl JT. Renal function in the fetus and neonate–the creatinine enigma. Paper presented at: Seminars in Fetal and Neonatal Medicine2017. 42. Sulemanji M, Vakili K. Neonatal renal physiology. Paper presented at: Seminars in pediatric surgery2013. 43. Koch G, Datta AN, Jost K, Schulzke SM, van den Anker J, Pfister M. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates. The Journal of pediatrics. 2017;191:50-56. e51. 44. van Donge T, Pfister M, Bielicki J, et al. Quantitative analysis of gentamicin exposure in neonates and infants calls into question its current dosing recommendations. Antimicrobial agents and chemotherapy. 2018:AAC. 02004-02017. 45. Wilbaux M, Kasser S, Wellmann S, Lapaire O, Van Den Anker JN, Pfister M. Characterizing and forecasting individual weight changes in term neonates. The Journal of pediatrics. 2016;173:101-107. e110. 46. Manolis E, Pons G. Proposals for model‐based paediatric medicinal development within the current European Union regulatory framework. British journal of clinical pharmacology. 2009;68(4):493-501. 47. Anderson GD. Pregnancy-induced changes in pharmacokinetics. Clinical pharmacokinetics. 2005;44(10):989-1008. 48. Morton SU, Brodsky D. Fetal physiology and the transition to extrauterine life. Clinics in perinatology. 2016;43(3):395-407.